No Data
No Data
Aadi Bioscience Downgraded to Neutral, Shares Fall
Piper Sandler Downgrades Aadi Biosciences(AADI.US) to Hold Rating, Cuts Target Price to $1.75
Express News | Aadi Bioscience Inc : Piper Sandler Cuts to Neutral From Overweight
Express News | Aadi Bioscience Inc - Desai Will Continue to Serve as a Member of Board
Express News | Aadi Bioscience Inc - on August 20, Neil Desai, Was Notified That His Employment as Executive Chairman of Company Will Cease on October 1, 2024
Express News | Aadi Bioscience Inc - Board Has Determined That Itri's Pending Cessation of Employment Is a Voluntary Resignation
No Data
No Data